Detalhe da pesquisa
1.
Adjuvant solution for pandemic influenza vaccine production.
Proc Natl Acad Sci U S A
; 109(43): 17585-90, 2012 Oct 23.
Artigo
Inglês
| MEDLINE | ID: mdl-23045649
2.
The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in nonhuman primates and has an extended half-life in humans.
Sci Transl Med
; 14(635): eabl8124, 2022 03 09.
Artigo
Inglês
| MEDLINE | ID: mdl-35076282
3.
Optimization of a multivalent peptide vaccine for nicotine addiction.
Vaccine
; 37(12): 1584-1590, 2019 03 14.
Artigo
Inglês
| MEDLINE | ID: mdl-30772068
4.
Epitope targeting with self-assembled peptide vaccines.
NPJ Vaccines
; 4: 30, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31341647
5.
Construction of an enantiopure bivalent nicotine vaccine using synthetic peptides.
PLoS One
; 12(6): e0178835, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-28570609
6.
Selection of therapeutic H5N1 monoclonal antibodies following IgVH repertoire analysis in mice.
Antiviral Res
; 131: 100-8, 2016 07.
Artigo
Inglês
| MEDLINE | ID: mdl-27109194
7.
Novel Anti-Nicotine Vaccine Using a Trimeric Coiled-Coil Hapten Carrier.
PLoS One
; 9(12): e114366, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-25494044
8.
GLA-AF, an emulsion-free vaccine adjuvant for pandemic influenza.
PLoS One
; 9(2): e88979, 2014.
Artigo
Inglês
| MEDLINE | ID: mdl-24551202
9.
Interleukin-21 enhances rituximab activity in a cynomolgus monkey model of B cell depletion and in mouse B cell lymphoma models.
PLoS One
; 8(6): e67256, 2013.
Artigo
Inglês
| MEDLINE | ID: mdl-23825648